Together, our results reveal an unexpected role for cholecystokinin in the lung and support the repurposing of cholecystokinin A receptor antagonists as a potential therapy for asthma patients with obesity. The gene discussed is CCKAR; the disease is obesity due to melanocortin 4 receptor deficiency.